In recent decades, Latin America (LA) has experienced profound demographic and epidemiologic changes conditioning an enormous increase in prevalence and incidence of chronic non-communicable diseases. End-stage renal disease has steadily increased in prevalence and incidence (478.2 and 168.7 pmp, respectively) and is emerging as a devastating medical, social, and economic problem for patients, families, and national health systems. The development of successful renal replacement treatment modalities has emphasized the wide breach in healthcare between developed and emerging nations. LA is composed of many nations that have a common social and cultural background yet exhibit significant variations in socioeconomic status, ethnicities, and human development. In addition, the region is experiencing a type 2 diabetes mellitus epidemic and a constant growth of related end-stage renal disease which at present is not sustainable and will be unaffordable in most countries, unless changes in public health policy and a new focus on the problem is generated. Renal transplantation, though increasing, cannot revert the growing prevalence. The development of public health policies and prevention programs is mandatory in LA and requires a better knowledge of prevalence and distribution of risk factors in the different nations of the region.
No takes yet. Share an insight, caveat, or question.
Correa‐Rotter et al. (2008) studied this question.